Share
Market Research Report

PLEURAL BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeBiopsy Needles and Instruments · Thoracoscopes and Accessories · Imaging and Guidance Systems · and Ancillary Equipment (suction devices, forceps, kits, etc.)
  • By TechniqueNeedle Biopsy (Closed Needle/Abrams Needle) · Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS) · and Open Surgical Pleural Biopsy
  • By Diagnostic ApplicationMalignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers) · Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis) · Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus) · and Other Idiopathic or Unexplained Pleural Effusions
  • By Guidance MethodImage-Guided (CT-guided, Ultrasound-guided) and Non-Guided
  • By End UserHospitals · Specialty Clinics · Diagnostic Centers · Ambulatory Surgical Centers · and Academic and Research Institutes
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In10 Mar 2026
  • Report CodeCMI8455
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Market Segmentation

  • Product Type Insights (Revenue, USD Mn, 2021 - 2033)

    • Biopsy Needles and Instruments
    • Thoracoscopes and Accessories
    • Imaging and Guidance Systems
    • Ancillary Equipment (suction devices, forceps, kits, etc.)
  • Technique Insights (Revenue, USD Mn, 2021 - 2033)

    • Needle Biopsy (Closed Needle/Abrams Needle)
    • Thoracoscopic Pleural Biopsy (Medical Thoracoscopy/VATS)
    • Open Surgical Pleural Biopsy
  • Diagnostic Application Insights (Revenue, USD Mn, 2021 - 2033)

    • Malignant Pleural Effusion and Pleural Malignancies (e.g., mesothelioma, metastatic cancers)
    • Infectious Pleural Diseases (e.g., tuberculosis, bacterial/fungal pleuritis)
    • Inflammatory and Autoimmune Conditions (e.g., rheumatoid pleuritis, lupus)
    • Other Idiopathic or Unexplained Pleural Effusions
  • Guidance Method Insights (Revenue, USD Mn, 2021 - 2033)

    • Image-Guided (CT-guided, Ultrasound-guided)
    • Non-Guided
  • End User Insights (Revenue, USD Mn, 2021 - 2033)

    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Ambulatory Surgical Centers
    • Academic and Research Institutes
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)

    • North America
      • U.S.
      • Canada
    • Latin America
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • GCC Countries
      • Israel
      • Rest of Middle East
    • Africa
      • South Africa
      • North Africa
      • Central Africa